— Know what they know.
Not Investment Advice
Also trades as: NXGLW (NASDAQ) · $vol 0M

NXGL NASDAQ

NEXGEL, Inc.
1W: +0.0% 1M: -49.9% 3M: -67.8% YTD: -90.4% 1Y: -92.8% 3Y: -91.1%
$0.17
-0.00 (-2.52%)
 
Weekly Expected Move ±18.4%
$0 $0 $0 $0 $0
NASDAQ · Healthcare · Medical - Instruments & Supplies · Tech Score Strong Sell · Power 22 · $1.5M mcap · 7M float · 9.83% daily turnover · Short 52% of daily vol

Cash Flow Trends

Operating Cash Flow
-$4M -19.5% ▼
Capital Expenditures
$443K +36.4% ▲
Free Cash Flow
-$4M -9.6% ▼
Dividends Paid
$0 +0.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
-$893K -155.8% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
— Operating Activities —
Net Income-$2M-$4M-$5M-$3M-$3M
Depreciation & Amort.$50K$113K$301K$443K$478K
Stock-Based Comp.$232K$285K$298K$217K$367K
Change in Working Capital$177K-$593K-$234K-$421K-$1M
Other Non-Cash Items$2K$2M$1M-$318K-$260K
Operating Cash Flow-$2M-$3M-$3M-$3M-$4M
— Investing Activities —
Capital Expenditures-$312K-$269K-$96K-$696K-$443K
Acquisitions (Net)$0$0$96K-$547K-$400K
Investment Purchases$0$0-$7M$500K$0
Investment Sales$0$0$2M$6M$68K
Other Investing$0$0-$96K-$500K$0
Investing Cash Flow-$312K-$269K-$6M$4M-$775K
— Financing Activities —
Net Debt Issuance$514K$3M-$4M$379K$218K
Stock Repurchased$0$0$0$0$0
Dividends Paid$0$0$0$0$0
Other Financing$0-$115K$0$0-$241K
Financing Cash Flow$2M$16M-$4M$379K$4M
Net Change in Cash-$229K$13M-$12M$2M-$893K
Cash End of Period$32K$13M$1M$3M$2M
Free Cash Flow-$2M-$3M-$3M-$4M-$4M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms